The Human Disharmony Loop (full) Including Inciting Factors. by James M. Friedman (22522150)

Subjects:

Baseline Severity of Disease by Scapular Dyskinesia Stage^1. by James M. Friedman (22522150)

Subjects:

The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

Subjects:

Normal Anatomy vs. Disharmonic Pathoanatomy. by James M. Friedman (22522150)

Subjects:

The Human Disharmony Loop (central). by James M. Friedman (22522150)

Subjects:

Sample Pain Diagrams. by James M. Friedman (22522150)

Subjects:

Patient Example. by James M. Friedman (22522150)

Subjects:

Characteristics of Study Participants. by Alix Boisson-Walsh (17847176)

“…<div><p>The COVID-19 pandemic negatively impacted routine immunizations worldwide, decreasing confidence in vaccination programs. We used mixed methods to examine changes in vaccine confidence from before to during the pandemic in HBV-negative adults in Kinshasa who were exposed to HBV in the household, and eligible for HBV vaccination. …”

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

Subjects:

Results from Ordinary Least Squares (OLS). by Muhummad Khairul Islam (21955544)

Subjects:

Correlation Matrix. by Muhummad Khairul Islam (21955544)

Subjects:

Multicollinearity Test. by Muhummad Khairul Islam (21955544)

Subjects:

Descriptive Statistics. by Muhummad Khairul Islam (21955544)

Subjects:

<i>Oenocarpus bacaba</i> palm tree (A) and fruit (B). by Eudes Alves Simões-Neto (19697968)

“…Serological cure was achieved in 34.6% of cases, and IgG titers decreased in 15.3%.</p><p>Conclusions and significance</p><p>We encountered several barriers in managing ACD, including population vulnerability, reliance on outdated diagnostic techniques, lack of standardized molecular biology methods, and limited therapeutic options. …”

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

Subjects:

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Subjects:

Patient background and blood culture-related factors before and after revision of the blood culture collection protocol. by Miki Doi (15347878)

Subjects:

Comparison of the blood culture contamination rate (per set) in each organism between the control and bundle periods. by Miki Doi (15347878)

Subjects:

Reasons for the determination of blood culture contamination for each organism. by Miki Doi (15347878)

Subjects:

Protocol for blood culture during the control period. by Miki Doi (15347878)

Subjects: